|
Hologic offers update on Gen-Probe purchase
 July 12, 2012 -- Women's imaging vendor Hologic and Gen-Probe announced that Carl Hull, chairman and CEO of Gen-Probe, has entered into an agreement to continue his employment with the combined company for a minimum of 15 months.
To view the remainder of this article, and other exclusive content, you must first sign-in or register using the options below.
(Helptag:PaywallArticleLoginMessage)
| |
|
|
New AuntMinnie.com Members
|
Becoming a Member is FREE!
|
Real-time radiology-specific news
Case of the Day and Teaching Files
Focused topics digital communities
Lively, discussion groups
Medical imaging bookstore
SalaryScan
Job Boards
OnLine CMe/CE
Bookstore, market reports, more …
Conference Calendar
User-controlled eNewsletters
… registration is FREE and easy!
|
| |
|
Hull will serve as senior vice president and general manager of the combined company's diagnostics business, which will include Gen-Probe's current operations, as well as Hologic's diagnostics segment, the two firms said. The companies also confirmed that integration planning efforts are well under way and continue to proceed as planned.
Hologic has launched marketing for $750 million in senior notes in a private offering expected to close concurrently with the completion of the company's acquisition of Gen-Probe, Hologic said. Gen-Probe has scheduled a special meeting of stockholders for July 31 to vote on the pending transaction, which is expected to close on or near August 1, 2012. | |
|